Diagnosis and management of patients with acute cardiac symptoms, troponin elevation and culprit-free angiograms

Heart

Volumn 98, Issue 13, 2012, Pages 974-981

  Gallagher, Sean ^a,b,c   Jones, Dan A ^a,b,c   Anand, Vijay ^a   Mohiddin, Saidi ^a,b,c  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; CARDIOVASCULAR MAGNETIC RESONANCE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HEART INFARCTION; HUMAN; MEDICAL LITERATURE; MYOCARDIAL BRIDGING; MYOCARDITIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TAKOTSUBO CARDIOMYOPATHY;

ACUTE CORONARY SYNDROME; CORONARY ANGIOGRAPHY; DIAGNOSIS, DIFFERENTIAL; HUMANS; MYOCARDIAL INFARCTION; MYOCARDITIS; TROPONIN;

EID: 84862022510     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-301121     Document Type: Review

References (63)

1. Myocardial Ischaemia National Audit Project. How the NHS Cares for Patients with Heart Attack. London, 2010.
2. Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010;30:1282-92.
3. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
4. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global use of strategies to Open Occluded coronary arteries in acute coronary syndromes IIb Investigators. N Engl J Med 1999;341:226-32.
5. Larsen AI, Galbraith PD, Ghali WA, et al APPROACH Investigators. Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 2005;95:261-3. (Pubitemid 40092096)
6. Maehara A, Mintz GS, Bui AB, et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 2002;40:904-10. (Pubitemid 35000496)
7. Ong P, Athanasiadis A, Hill S, et al. Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary artery spasm in patients with acute coronary syndrome) study. J Am Coll Cardiol 2008;52:523-7.
8. Januzzi JLJ, Bamberg F, Lee H, et al. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 2010;121:1227-34.
9. Baccouche H, Mahrholdt H, Meinhardt G, et al. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J 2009;30:2869-79.
10. Laraudogoitia Zaldumbide E, Perez-David E, Larena JA, et al. The value of cardiac magnetic resonance in patients with acute coronary syndrome and normal coronary arteries. Rev Esp Cardiol 2009;62:976-83.
11. Monney PA, Sekhri N, Burchell T, et al. Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart 2011;97:1312-18.
12. Patel MR, Chen AY, Peterson ED, et al. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. Am Heart J 2006;152:641-7. (Pubitemid 44396875)
13. Roe MT, Harrington RA, Prosper DM, et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation 2000;102:1101-6.
14. Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med 1998;338:1785-92. (Pubitemid 28277958)
15. Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 2000;356:9-16. (Pubitemid 30416988)
16. Dokainish H, Pillai M, Murphy SA, et al. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 2005;45:19-24. (Pubitemid 40052020)
17. Cortell A, Sanchis J, Bodi V, et al. Non-ST-elevation acute myocardial infarction with normal coronary arteries: predictors and prognosis. Rev Esp Cardiol 2009;62:1260-6.
18. Kang WY, Jeong MH, Ahn YK, et al. Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe? Int J Cardiol 2011;146:207-12.
19. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42. (Pubitemid 37010777)
20. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825-9. (Pubitemid 35257945)
21. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-66. (Pubitemid 34983245)
22. Widimsky P, Stellova B, Groch L, et al. Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: experience from the PRAGUE studies. Can J Cardiol 2006;22:1147-52. (Pubitemid 44932382)
23. Prasad SB, Richards DA, Sadick N, et al. Clinical and electrocardiographic correlates of normal coronary angiography in patients referred for primary percutaneous coronary intervention. Am J Cardiol 2008;102:155-9.
24. Gu YL, Svilaas T, van der Horst IC, et al. Conditions mimicking acute ST-segment elevation myocardial infarction in patients referred for primary percutaneous coronary intervention. Neth Heart J 2008;16:325-31.
25. Larson DM, Menssen KM, Sharkey SW, et al. "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. JAMA 2007;298:2754-60. (Pubitemid 350294298)
26. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke Statistics - 2010 Update: a report from the American heart association. Circulation 2010;121:e46-215.
27. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38. (Pubitemid 47616190)
28. Assomull RG, Lyne JC, Keenan N, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 2007;28:1242-9. (Pubitemid 47343853)
29. Laissy JP, Hyafil F, Feldman LJ, et al. Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology 2005;237:75-82. (Pubitemid 41346148)
30. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009;53:1475-87.
31. Nef HM, Mollmann H, Elsasser A. Tako-tsubo cardiomyopathy (apical ballooning). Heart 2007;93:1309-15. (Pubitemid 47492929)
32. Edwards NC, Routledge H, Steeds RP. T2-weighted magnetic resonance imaging to assess myocardial oedema in ischaemic heart disease. Heart 2009;95:1357-61.
33. Leurent G, Langella B, Fougerou C, et al. Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries. Arch Cardiovasc Dis 2011;104:161-70.
34. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
35. Rehwald WG, Fieno DS, Chen EL, et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105:224-9. (Pubitemid 34084323)
36. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103:2780-3. (Pubitemid 32550063)
37. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45:1815-22. (Pubitemid 40779862)
38. Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008;246:401-9.
39. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-9. (Pubitemid 28213624)
40. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006;113:593-5.
41. Cooper LT. Myocarditis. N Engl J Med 2009;360:1526-38.
42. McCarthy RE 3rd, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-5. (Pubitemid 30131421)
43. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American heart association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007;116:2216-33. (Pubitemid 350060359)
44. Choi JO, Yun SH, Sung K, et al. Thioredoxin, adiponectin and clinical course of acute fulminant myocarditis. Heart 2011;97:1067-73.
45. Escher F, Westermann D, Gaub R, et al. Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis. Heart 2011;97:709-14.
46. Sato H, Tateishi H, Uchida T, et al. Tako-tsubo-like Left Ventricular Dysfunction Due to Multivessel Coronary Spasm. Tokyo: Kagakuhyoronsha Publishing Co, 1990.
47. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
48. Hurst RT, Prasad A, Askew JW 3rd, et al. Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging 2010;3:641-9.
49. Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA 2011;306:277-86.
50. Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 2005;111:472-9. (Pubitemid 40204432)
51. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62.
52. Reynolds HR, Srichai MB, Iqbal SN, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 2011;124:1414-25.
53. Lanza GM, Berman BJ, Tanuchi M. Multifocal coronary thromboembolism from a left ventricular thrombus. N Engl J Med 1999;341:1083-4. (Pubitemid 29451810)
54. Cheng TO. Coronary embolism. Int J Cardiol 2009;136:1-3.
55. Dao CN, Tobis JM. PFO and paradoxical embolism producing events other than stroke. Catheter Cardiovasc Interv 2011;77:903-9.
56. Crump R, Shandling AH, Van Natta B, et al. Prevalence of patent foramen ovale in patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 2000;85:1368-70. (Pubitemid 30314674)
57. Linnemann B, Schindewolf M, Zgouras D, et al. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? Thromb Res 2008;121:743-50. (Pubitemid 351492581)
58. Dacosta A, Tardy-Poncet B, Isaaz K, et al. Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries. Heart 1998;80:338-40. (Pubitemid 28470763)
59. Prinzmetal M, Kennamer R, Merliss R, et al. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med 1959;27:375-88.
60. Da Costa A, Isaaz K, Faure E, et al. Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction with an absolutely normal coronary angiogram; a 3-year follow-up study of 91 patients. Eur Heart J 2001;22:1459-65. (Pubitemid 32769173)
61. Wang CH, Kuo LT, Hung MJ, et al. Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease. Am Heart J 2002;144:275-81. (Pubitemid 34879651)
62. Yilmaz A, Mahrholdt H, Athanasiadis A, et al. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart 2008;94:1456-63.
63. Mohiddin SA, Fananapazir L. Systolic compression of epicardial coronary and intramural arteries in children with hypertrophic cardiomyopathy. Tex Heart Inst J 2002;29:290-8. (Pubitemid 35435212)